Literature DB >> 3264575

Stimulation of human synovial fibroblast DNA synthesis by recombinant human cytokines.

D M Butler1, D S Piccoli, P H Hart, J A Hamilton.   

Abstract

The pronounced synovial hyperplasia often found in rheumatoid joints can be explained at least partially, by the interaction of monocyte-macrophage polypeptides (monokines) and lymphocyte polypeptides (lymphokines) with synovial fibroblast-like cells. We now report that purified recombinant human cytokines, interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor alpha, tumor necrosis factor beta (or lymphotoxin) and, to a variable extent, interferon-gamma, stimulate the DNA synthesis of human synovial fibroblast-like cells cultured in low (i.e., 1%) fetal bovine serum. With the exception of interferon-gamma, the effects of the cytokines were generally elevated by indomethacin, suggesting inhibition of the DNA synthesis by an endogenously produced cyclooxygenase product(s). Consistent with this suggestion, exogenous prostaglandin E2 suppressed cytokine induced DNA synthesis. All of the cytokines studied might play a role in the synovial hyperplasia present in rheumatoid disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264575

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

Review 1.  Molecular mechanism of immune response, synovial proliferation and apoptosis in rheumatoid arthritis.

Authors:  T Hasunuma; T Kato; T Kobata; K Nishioka
Journal:  Springer Semin Immunopathol       Date:  1998

Review 2.  The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.

Authors:  G Kollias; E Douni; G Kassiotis; D Kontoyiannis
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

3.  Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes.

Authors:  J M Alvaro-Gracia; N J Zvaifler; G S Firestein
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

4.  Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts.

Authors:  Hideo Inoue; Makiko Takamori; Yoshihito Shimoyama; Hideaki Ishibashi; Seizo Yamamoto; Yasuko Koshihara
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

5.  Reduction of tumor necrosis factor alpha and interleukin-1 beta levels in human synovial tissue by interleukin-4 and glucocorticoid.

Authors:  A Bendrups; A Hilton; A Meager; J A Hamilton
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

6.  Ceramide, a mediator of interleukin 1, tumour necrosis factor alpha, as well as Fas receptor signalling, induces apoptosis of rheumatoid arthritis synovial cells.

Authors:  N Mizushima; H Kohsaka; N Miyasaka
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103

7.  Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.

Authors:  J A Hamilton; D S Piccoli; T Leizer; D M Butler; M Croatto; A K Royston
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

8.  Identification of the major fibroblast growth factors released spontaneously in inflammatory arthritis as platelet derived growth factor and tumour necrosis factor-alpha.

Authors:  S C Thornton; S B Por; R Penny; M Richter; L Shelley; S N Breit
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

9.  Microheterogeneity of acute phase proteins in patients with clinically active and clinically nonactive osteoarthritis.

Authors:  P Hrycaj; T Stratz; C Kovac; P Mennet; W Müller
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

10.  The differential effects of stanozolol on human skin and synovial fibroblasts in vitro: DNA synthesis and receptor binding.

Authors:  A J Ellis; T E Cawston; E J Mackie
Journal:  Agents Actions       Date:  1994-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.